Narcolepsy Drugs Market

Narcolepsy Drugs Market - Global Market Share, Trends, Analysis and Forecast, 2023-2032
Frequently asked questions about this report

The narcolepsy drugs market is expected to grow at a CAGR of 10.5% between 2023 to 2032.

The covid-19 pandemic negatively impacted the growth of global narcolepsy drugs due to reduced demand for non-essential therapies and a reduction in the number of patients.

Arena Pharmaceutical, Inc., Addrenex Pharmaceuticals, Bioprojet Pharma SRL, GrayMark Healthcare Inc., Novartis AG., Jazz Pharmaceuticals Plc., Ligand Pharmaceuticals Inc, Shire Plc, Teva Pharmaceutical Industries Ltd., etc are some of the major players in the global narcolepsy drugs market.

The narcolepsy drugs market size was estimated to be US$ 4.1 billion in 2021

Narcolepsy drugs are used for the treatment of hypersomnia symptoms like Daytime Extreme Sleepiness, Cataplexia, etc.

The rising incidence of narcolepsy increased understanding of sleep disorders as a result of narcolepsy educational campaigns and awareness programs, and the expanding prevalence of favourable reimbursement are the biggest factors driving the expansion of the global narcolepsy drugs market.